Physician profile
Guillermo Philipps
NPI 1992943781
$3,931.20
in general payments reported to CMS, 2019-2025
33 companies · $1,171 in 2025
The $1,171 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $935 · 2020: $208 · 2021: $31.82 · 2022: $875 · 2023: $484 · 2024: $225 · 2025: $1,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,639 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $200 · Education: $41.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,639.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $200.00 |
| Education | $41.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ptc Therapeutics, INC. | $720.00 | 2022 | |
| Livanova USA, INC. | $458.90 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Ucb, INC. | $413.53 | 2019-2025 | Fintepla, Briviact |
| Sk Life Science, INC. | $343.60 | 2022-2025 | Xcopri |
| Catalyst Pharmaceuticals, INC. | $238.32 | 2025 | |
| Acadia Pharmaceuticals INC | $216.90 | 2024-2025 | Daybue |
| Novartis Gene Therapies, INC. (Fka Avexis, INC.) | $191.07 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $148.18 | 2019-2020 | |
| Genentech USA, INC. | $137.99 | 2023-2025 | Evrysdi |
| Supernus Pharmaceuticals, INC. | $130.07 | 2019-2023 | Qelbree |
| Sumitomo Pharma America, INC. | $123.45 | 2023 | Aptiom |
| Jazz Pharmaceuticals INC. | $112.63 | 2019-2025 | |
| Biogen, INC. | $110.36 | 2019 | |
| Ironshore Pharmaceuticals INC. | $78.04 | 2019-2021 | |
| Aucta Pharmaceuticals, INC. | $55.17 | 2025 | Motpoly Xr |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otter Pharmaceuticals, LLC | $46.39 | 2025 | Sympazan |
| Collegium Pharmaceutical, INC. | $42.30 | 2025 | Jornay Pm |
| Tris Pharma INC | $36.85 | 2019 | |
| Novartis Pharmaceuticals Corporation | $33.12 | 2019 | |
| Aquestive Therapeutics, INC. | $31.45 | 2019 | |
| Itf Therapeutics LLC | $26.95 | 2025 | |
| Corium, LLC | $26.04 | 2022 | |
| Azurity Pharmaceuticals, INC. | $25.41 | 2025 | Zonisade |
| Nobelpharma America, LLC | $25.00 | 2024 | |
| Sarepta Therapeutics, INC. | $22.56 | 2025 | Elevidys |
| Eisai INC. | $22.56 | 2019 | |
| Soleno Therapeutics, INC. | $20.57 | 2025 | Vykat Xr |
| Neurelis, INC. | $18.95 | 2025 | Valtoco |
| Springworks Therapeutics, INC. | $18.13 | 2025 | Gomekli |
| Zogenix INC. | $16.68 | 2021 | |
| Saol Therapeutics INC. | $14.34 | 2019 | |
| Travere Therapeutics, INC. | $13.51 | 2019 | |
| Mallinckrodt Enterprises LLC | $12.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guillermo Philipps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.